Literature DB >> 22120421

Phenotypes, genotypes, serotypes and molecular epidemiology of erythromycin-resistant Streptococcus agalactiae in Italy.

M A De Francesco1, S Caracciolo, F Gargiulo, N Manca.   

Abstract

The purpose of this investigation was to analyse Streptococcus agalactiae (group B Streptococcus, GBS) isolates collected in Italy from vaginal and urine samples in respect to their clonality, distribution of virulence factors and antimicrobial resistance determinants. Three hundred and eighty-eight GBS were recovered from clinical samples. They were analysed for antibiotic resistance profiling. Erythromycin-resistant strains were further characterised by multilocus sequence typing (MLST), serotyping and the detection of alp genes of the alpha-like protein (Alp) family. GBS isolates represented 40 different sequence types (STs), grouped in five clonal complexes (CCs) and belonged to seven serotypes. Most serotype V strains (81%) possessed alp2-3; serotype Ia carried mainly epsilon, while the serotype III mainly rib. All isolates were susceptible to penicillin, whereas resistance to erythromycin was detected in 15% of isolates. Most erythromycin-resistant GBS strains were of serotype V (56.8%) and belonged to the CC-1 group (50%). Macrolide resistance phenotypes were the cMLS(B) (46.5%) and the M phenotypes (46.5%) due to the presence of ermB and mefA/E genes, respectively. These results provide data which establish a baseline for monitoring erythromycin resistance in this region and also provide an insight into the correlation among clonal types, serotypes, surface protein and resistance genes. The increased prevalence of strains that displayed the M phenotype strengthens the importance of the epidemiological surveillance of macrolide resistance in GBS, which may also represent an important reservoir of resistance genes for other species.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22120421     DOI: 10.1007/s10096-011-1495-4

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  37 in total

1.  Presence of mefA and mefE genes in Streptococcus agalactiae.

Authors:  C Arpin; H Daube; F Tessier; C Quentin
Journal:  Antimicrob Agents Chemother       Date:  1999-04       Impact factor: 5.191

2.  Mechanisms of macrolide resistance in clinical group B streptococci isolated in France.

Authors:  F Fitoussi; C Loukil; I Gros; O Clermont; P Mariani; S Bonacorsi; I Le Thomas; D Deforche; E Bingen
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

3.  Molecular characterization and antimicrobial susceptibility profiles in Streptococcus agalactiae colonizing strains: association of erythromycin resistance with subtype III-1 genetic clone family.

Authors:  C Florindo; S Viegas; A Paulino; E Rodrigues; J P Gomes; M J Borrego
Journal:  Clin Microbiol Infect       Date:  2010-09       Impact factor: 8.067

Review 4.  Surface proteins of Streptococcus agalactiae and related proteins in other bacterial pathogens.

Authors:  Gunnar Lindahl; Margaretha Stålhammar-Carlemalm; Thomas Areschoug
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

5.  The projected health benefits of maternal group B streptococcal vaccination in the era of chemoprophylaxis.

Authors:  Anushua Sinha; Tracy A Lieu; Lawrence C Paoletti; Milton C Weinstein; Richard Platt
Journal:  Vaccine       Date:  2005-05-02       Impact factor: 3.641

Review 6.  Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications.

Authors:  Roland Leclercq
Journal:  Clin Infect Dis       Date:  2002-01-11       Impact factor: 9.079

7.  Antibiotic susceptibility profiles for group B streptococci isolated from neonates, 1995-1998.

Authors:  F Y Lin; P H Azimi; L E Weisman; J B Philips; J Regan; P Clark; G G Rhoads; J Clemens; J Troendle; E Pratt; R A Brenner; V Gill
Journal:  Clin Infect Dis       Date:  2000-07-24       Impact factor: 9.079

8.  Serotypes VI and VIII predominate among group B streptococci isolated from pregnant Japanese women.

Authors:  C S Lachenauer; D L Kasper; J Shimada; Y Ichiman; H Ohtsuka; M Kaku; L C Paoletti; P Ferrieri; L C Madoff
Journal:  J Infect Dis       Date:  1999-04       Impact factor: 5.226

9.  Characterization of Streptococcus agalactiae strains by multilocus enzyme genotype and serotype: identification of multiple virulent clone families that cause invasive neonatal disease.

Authors:  R Quentin; H Huet; F S Wang; P Geslin; A Goudeau; R K Selander
Journal:  J Clin Microbiol       Date:  1995-10       Impact factor: 5.948

10.  Multilocus sequence typing system for group B streptococcus.

Authors:  Nicola Jones; John F Bohnsack; Shinji Takahashi; Karen A Oliver; Man-Suen Chan; Frank Kunst; Philippe Glaser; Christophe Rusniok; Derrick W M Crook; Rosalind M Harding; Naiel Bisharat; Brian G Spratt
Journal:  J Clin Microbiol       Date:  2003-06       Impact factor: 5.948

View more
  16 in total

1.  Distribution of pilus islands and alpha-like protein genes of group B Streptococcus colonized in pregnant women in Beijing, China.

Authors:  B Lu; D Wang; H Zhou; F Zhu; D Li; S Zhang; Y Shi; Y Cui; L Huang; H Wu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-02-11       Impact factor: 3.267

2.  Emergence of the first levofloxacin-resistant strains of Streptococcus agalactiae isolated in Italy.

Authors:  G Piccinelli; F Gargiulo; S Corbellini; G Ravizzola; C Bonfanti; A Caruso; M A De Francesco
Journal:  Antimicrob Agents Chemother       Date:  2015-02-09       Impact factor: 5.191

3.  High Incidence of Pathogenic Streptococcus agalactiae ST485 Strain in Pregnant/Puerperal Women and Isolation of Hyper-Virulent Human CC67 Strain.

Authors:  Liping Li; Rui Wang; Yan Huang; Ting Huang; Fuguang Luo; Weiyi Huang; Xiuying Yang; Aiying Lei; Ming Chen; Xi Gan
Journal:  Front Microbiol       Date:  2018-02-06       Impact factor: 5.640

4.  Molecular epidemiology and distribution of serotypes, genotypes, and antibiotic resistance genes of Streptococcus agalactiae clinical isolates from Guelma, Algeria and Marseille, France.

Authors:  A Bergal; L Loucif; D E Benouareth; A A Bentorki; C Abat; J-M Rolain
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-09-28       Impact factor: 3.267

5.  In vitro activity of solithromycin against erythromycin-resistant Streptococcus agalactiae.

Authors:  Giorgio Piccinelli; Prabhavathi Fernandes; Carlo Bonfanti; Francesca Caccuri; Arnaldo Caruso; Maria Antonia De Francesco
Journal:  Antimicrob Agents Chemother       Date:  2013-12-30       Impact factor: 5.191

6.  Streptococcus agalactiae from pregnant women: antibiotic and heavy-metal resistance mechanisms and molecular typing.

Authors:  B Rojo-Bezares; J M Azcona-Gutiérrez; C Martin; M S Jareño; C Torres; Y Sáenz
Journal:  Epidemiol Infect       Date:  2016-08-08       Impact factor: 4.434

7.  Evidence of Common Isolates of Streptococcus agalactiae in Bovines and Humans in Emilia Romagna Region (Northern Italy).

Authors:  Elena Carra; Simone Russo; Alessia Micheli; Chiara Garbarino; Matteo Ricchi; Federica Bergamini; Patrizia Bassi; Alice Prosperi; Silvia Piva; Monica Cricca; Roberta Schiavo; Giuseppe Merialdi; Andrea Serraino; Norma Arrigoni
Journal:  Front Microbiol       Date:  2021-06-11       Impact factor: 5.640

8.  Streptococcus agalactiae clones infecting humans were selected and fixed through the extensive use of tetracycline.

Authors:  Violette Da Cunha; Mark R Davies; Pierre-Emmanuel Douarre; Isabelle Rosinski-Chupin; Immaculada Margarit; Sebastien Spinali; Tim Perkins; Pierre Lechat; Nicolas Dmytruk; Elisabeth Sauvage; Laurence Ma; Benedetta Romi; Magali Tichit; Maria-José Lopez-Sanchez; Stéphane Descorps-Declere; Erika Souche; Carmen Buchrieser; Patrick Trieu-Cuot; Ivan Moszer; Dominique Clermont; Domenico Maione; Christiane Bouchier; David J McMillan; Julian Parkhill; John L Telford; Gordan Dougan; Mark J Walker; Matthew T G Holden; Claire Poyart; Philippe Glaser
Journal:  Nat Commun       Date:  2014-08-04       Impact factor: 14.919

9.  Molecular Characterization of Streptococcus agalactiae Isolates From Pregnant and Non-Pregnant Women at Yazd University Hospital, Iran.

Authors:  Maryam Sadeh; Roya Firouzi; Abdollah Derakhshandeh; Mohammad Bagher Khalili; Fanrong Kong; Timothy Kudinha
Journal:  Jundishapur J Microbiol       Date:  2016-02-15       Impact factor: 0.747

10.  Molecular Characterization of Streptococcus agalactiae Causing Community- and Hospital-Acquired Infections in Shanghai, China.

Authors:  Haoqin Jiang; Mingliang Chen; Tianming Li; Hong Liu; Ye Gong; Min Li
Journal:  Front Microbiol       Date:  2016-08-30       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.